Cutting edge: Analysis of human Vα24+CD8+ NKT cells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells

Journal of Immunology

Volumn 168, Issue 7, 2002, Pages 3140-3144

  Takahashi, Tsuyoshi ^a   Chiba, Shigeru ^a   Nieda, Mie ^a   Azuma, Takeshi ^a   Ishihara, Soichiro ^a   Shibata, Yoichi ^a   Juji, Takeo ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GALACTOSYLCERAMIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0036533698     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.7.3140     Document Type: Article

References (28)

1. + T cells
2. + T cell receptor α/β cells: New clues to their origin, specificity and function
3. A novel population of T cell receptor αβ-bearing thymocytes which predominantly expresses a single Vβ8 gene family
4. Developmentally regulated expression of T cell receptor β chain variable domains in immature thymocytes
5. - T cells in mice and humans
6. - T cells
7. - and heterogenous with respect to TCRβ expression
8. + thymocytes selected by MHC class I molecules
9. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains
10. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells
11. +NKT cells
12. + NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets
13. a 14 NKT cells by glycosylceramides
14. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
15. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
16. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner
17. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
18. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
19. -T cells
20. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1
21. Mouse CD1-specific NK1 T cells: Development, specificity, and function
22. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells
23. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
24. Immune suppression and skin cancer development: Regulation by NKT cells
25. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
26. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes
27. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis
28. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes